Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1983 1
1985 1
1986 5
1987 1
1988 2
1989 4
1990 3
1991 4
1992 3
1993 4
1994 6
1995 4
1996 5
1997 5
1998 11
1999 11
2000 13
2001 5
2002 5
2003 5
2004 12
2005 10
2006 12
2007 10
2008 10
2009 13
2010 9
2011 16
2012 15
2013 12
2014 16
2015 18
2016 13
2017 5
2018 9
2019 7
2020 8
2021 6
2022 12
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.
Levy AS, Krailo M, Chi S, Villaluna D, Springer L, Williams-Hughes C, Fouladi M, Gajjar A. Levy AS, et al. Pediatr Blood Cancer. 2021 Aug;68(8):e29031. doi: 10.1002/pbc.29031. Epub 2021 Apr 12. Pediatr Blood Cancer. 2021. PMID: 33844469 Free PMC article. Clinical Trial.
This study compared the overall survival (OS) of patients receiving temozolomide (TMZ) and irinotecan with that of patients receiving TMZ, irinotecan, and bevacizumab for recurrent MB/central nervous system (CNS) primitive neuroectodermal tumor (PNET). METHOD …
This study compared the overall survival (OS) of patients receiving temozolomide (TMZ) and irinotecan with that of patients receiving TMZ, i …
Ewing Sarcoma and the History of Similar and Possibly Related Small Round Cell Tumors: From Whence Have We Come and Where are We Going?
Kilpatrick SE, Reith JD, Rubin B. Kilpatrick SE, et al. Adv Anat Pathol. 2018 Sep;25(5):314-326. doi: 10.1097/PAP.0000000000000203. Adv Anat Pathol. 2018. PMID: 29911999 Review.
Since its initial discovery by Dr James Ewing, the historical context of what is acceptably included under the designation "Ewing sarcoma" has changed. Although Ewing sarcoma and primitive neuroectodermal tumor were both initially described in the early 20th …
Since its initial discovery by Dr James Ewing, the historical context of what is acceptably included under the designation "Ewing sarcoma" h …
Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
Harris RD, Richard MA, Gramatges MMJ, Wilhelm K, Scheurer ME, Lupo PJ, Brown AL. Harris RD, et al. Pediatr Hematol Oncol. 2023 May;40(4):407-411. doi: 10.1080/08880018.2022.2101722. Epub 2022 Jul 21. Pediatr Hematol Oncol. 2023. PMID: 35862575
DNA methylation (DNAm) age is an emerging epigenetic biomarker of physiologic age and may be predictive of chronic health conditions in long-term survivors. This report describes the course of epigenetic age acceleration using post-diagnosis blood samples (median: 3.9 year …
DNA methylation (DNAm) age is an emerging epigenetic biomarker of physiologic age and may be predictive of chronic health conditions …
Radiologic and clinicopathologic findings of peripheral primitive neuroectodermal tumors.
Ba L, Tan H, Xiao H, Guan Y, Gao J, Gao X. Ba L, et al. Acta Radiol. 2015 Jul;56(7):820-8. doi: 10.1177/0284185114539321. Epub 2014 Jul 29. Acta Radiol. 2015. PMID: 25073463
All lesions enhanced heterogeneously with cystic changes. Homer-Wright rosettes were observed in 15 lesions, and 97.1% lesions were positive for CD99 in histopathological results. ...
All lesions enhanced heterogeneously with cystic changes. Homer-Wright rosettes were observed in 15 lesions, and 97.1% lesions were p …
Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.
Larson JD, Largaespada DA. Larson JD, et al. In Vivo. 2012 Jul-Aug;26(4):487-500. In Vivo. 2012. PMID: 22773561 Free PMC article. Review.
Primitive neuroectodermal tumors (PNET) of the brain include medulloblastoma (MB) and central nervous system primitive neuroectodermal tumor (CNS PNET) subtypes, which share histological features yet differ at the genomic level and in clinical outcome. ...Imp …
Primitive neuroectodermal tumors (PNET) of the brain include medulloblastoma (MB) and central nervous system primitive neuroectode
Renal Ewing tumors.
Zöllner S, Dirksen U, Jürgens H, Ranft A. Zöllner S, et al. Ann Oncol. 2013 Sep;24(9):2455-61. doi: 10.1093/annonc/mdt215. Epub 2013 Jun 11. Ann Oncol. 2013. PMID: 23761687 Free article.
BACKGROUND: Renal Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) is extremely rare. Clinical symptoms are nonspecific presenting abdominal pain, palpable mass, and hematuria. ...Twenty-four patients were identified and analyzed. The median time of …
BACKGROUND: Renal Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) is extremely rare. Clinical symptoms are no …
Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations.
Oliva E. Oliva E. Int J Gynecol Pathol. 2014 Jul;33(4):374-84. doi: 10.1097/PGP.0000000000000141. Int J Gynecol Pathol. 2014. PMID: 24901397 Review.
Other tumors that rarely occur in the uterus that are densely cellular include but are not limited to undifferentiated uterine sarcoma, embryonal rhabdomyosarcoma, primitive neuroectodermal tumor, lymphoma or small cell, or undifferentiated carcinoma. ...
Other tumors that rarely occur in the uterus that are densely cellular include but are not limited to undifferentiated uterine sarcoma, embr …
Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line.
Du N, Bao W, Zhang K, Lu X, Crew R, Wang X, Liu G, Wang F. Du N, et al. BMC Cancer. 2019 May 2;19(1):412. doi: 10.1186/s12885-019-5625-1. BMC Cancer. 2019. PMID: 31046733 Free PMC article.
Despite the use of this cell line as an in vitro model for functional and therapeutic studies of malignant primitive neuroectodermal tumor (PNET), there is a lack of complete information about the genetic alterations that are present at the cytogenetic level. …
Despite the use of this cell line as an in vitro model for functional and therapeutic studies of malignant primitive neuroectoderm
288 results